- 专利标题： CD137 ANTIBODIES AND TUMOR ANTIGEN-TARGETING ANTIBODIES AND USES THEREOF
-
申请号： PCT/US2018/061970申请日： 2018-11-20
-
公开(公告)号： WO2019100052A2公开(公告)日： 2019-05-23
- 发明人: TIGHE, Robert, V.,III , ESKIOCAK, Ugur
- 申请人： COMPASS THERAPEUTICS LLC
- 申请人地址： 245 First Street, Third Floor Cambridge, MA 02142 US
- 专利权人： COMPASS THERAPEUTICS LLC
- 当前专利权人： COMPASS THERAPEUTICS LLC
- 当前专利权人地址： 245 First Street, Third Floor Cambridge, MA 02142 US
- 代理机构： MANDRAGOURAS, Amy, E. et al.
- 优先权： US62/588,764 20171120; US62/754,764 20181102
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61P35/00 ; A61K39/395
摘要：
The present disclosure relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering combinations of antibodies, or antigen- binding fragments thereof, that bind to CD137, and tumor antigen-targeting antibodies.
公开/授权文献
